|
Volumn 31, Issue 1, 2009, Pages 33-37
|
Prognostic significance of ERCC1 mRNA expression in patients with non-small cell lung cancer receiving platinum-based chemotherapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DNA BINDING PROTEIN;
ENDONUCLEASE;
ERCC1 PROTEIN, HUMAN;
MESSENGER RNA;
PARAFFIN;
PLATINUM;
ADULT;
AGED;
ARTICLE;
BONE TUMOR;
BRAIN TUMOR;
CANCER STAGING;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLOW UP;
GENETICS;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
LYMPH NODE METASTASIS;
MALE;
METABOLISM;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PROPORTIONAL HAZARDS MODEL;
SURVIVAL RATE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
BRAIN NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DISEASE-FREE SURVIVAL;
DNA-BINDING PROTEINS;
ENDONUCLEASES;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PARAFFIN EMBEDDING;
PLATINUM;
PROPORTIONAL HAZARDS MODELS;
RNA, MESSENGER;
SURVIVAL RATE;
|
EID: 77955872831
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|